Posts by Jordan S. Sherwood, MD
-
Bionic Pancreas Improves Glycemic Control in Patients With Cystic Fibrosis-related Diabetes
Melissa Putman, MD, Jordan Sherwood, MD, and colleagues report that the insulin-only iLet bionic pancreas improved glucose control in patients with cystic fibrosis-related diabetes (CFRD) compared to usual care, without an increase in continuous glucose monitoring-measured hypoglycemia.
-
Review: Use of Diabetes Technology by Patients With Cystic Fibrosis
Melissa S. Putman, MD, Jordan S. Sherwood, MD, and colleagues give practical tips for how patients with cystic fibrosis–related diabetes can make the best use of continuous glucose monitors, insulin pumps and automated insulin delivery systems.
Biography
Jordan Sherwood, MD, is a pediatric endocrinologist with particular interests in diabetes and diabetes technology. He completed pediatric residency at Mass General for Children (MGfC), and a fellowship in pediatric endocrinology at MGfC. Dr. Sherwood is active in research with a focus on clinical trials of artificial pancreas technology for the management of diabetes. He has presented his work at regional, national and international forums.